FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations
- Details
- Category: Pfizer

Sanofi Pasteur to Develop & Commercialize Vaccine to Prevent Staphylococcus infections
- Details
- Category: Sanofi

GSK publishes speaking, consulting fees paid to US healthcare professionals
- Details
- Category: GlaxoSmithKline

Array BioPharma and Amgen Partner in Type 2 Diabetes
- Details
- Category: Amgen

Takeda and Pfizer to Co-Promote Takeda's Actos® for the Treatment of Type 2 Diabetes in China
- Details
- Category: Pfizer

Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems
- Details
- Category: Abbott

GSK and Intercell form strategic alliance to develop and commercialise innovative vaccines
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- Pfizer Extends Commitment to Help Unemployed Americans
- Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System
- Novartis Tasigna® trial shows superior results to Glivec®
- Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab
- Novo Nordisk starts phase 1 trial with oral insulin analogue
- Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University
- New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists